Using an unbiased genetic screen, To et al. map genes that enhance or suppress growth defects in response to different mitochondrial inhibitors to model mitochondrial disease. The findings have novel implications for the interconnectivity of bioenergetic pathways, and suggest a provocative strategy to treat primary mitochondrial disorders.
Keywords: CRISPR screen; GPX4; complex I; mitochondrial toxins.
Copyright © 2019. Published by Elsevier Ltd.